Patents for A61K 49 - Preparations for testing in vivo (35,376)
01/2001
01/02/2001US6168777 In vivo delivery of radioactive compositions which are delivered as a fluid to the solid mass tumor; subsequent solidification of this composition in the prostate results in delivery of a controlled amount of radiation to the prostate.
01/02/2001US6168776 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
01/02/2001CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof
12/2000
12/28/2000WO2000078776A2 Thiophene a2a receptor agonists
12/28/2000WO2000078774A2 Induction of pharmacological stress with adenosine receptor agonists
12/28/2000WO2000078361A2 Methods of imaging and targeting tumor vasculature
12/28/2000WO2000078228A1 Absorbable sponge with contrasting agent
12/28/2000WO2000046343A3 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation
12/28/2000WO2000032240A3 Radioconjugation of internalizing antibodies
12/28/2000CA2377188A1 Methods of imaging and targeting tumor vasculature
12/28/2000CA2371841A1 Absorbable sponge with contrasting agent
12/27/2000EP1062323A2 Methods of diagnosis and triage using cell activation measures
12/27/2000EP1061988A1 Gynecologic endovascular embolotherapy methods
12/27/2000EP1061957A1 Manganese chelates with high relaxivity in serum
12/27/2000EP1061956A1 Manganese chelates with high relaxivity in serum
12/27/2000EP1061930A1 Supercritical conditioned gas mixture containing co 2?, no and optionally a neutral gas
12/27/2000EP1061905A2 Methods and compositions for detection and diagnosis of infectious diseases
12/27/2000EP0832054B1 Heterocyclic methyl free radicals as image enhancing agents
12/27/2000CN1059837C 肿瘤诊断试剂 Tumor diagnostics
12/26/2000US6166200 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165722 Representations of bimolecular interactions
12/26/2000US6165443 Method for visually demonstrating the effectiveness of an antibacteria attachment composition
12/26/2000US6165442 Thermally stabilized ultrasound contrast agent
12/26/2000US6165378 Polysaccharide derivative/magnetic metal oxide composite
12/21/2000WO2000077039A2 Glp-1 as a diagnostic test to determine beta-cell function
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076987A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076555A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
12/21/2000WO2000076551A2 Method for producing an injectable medicament preparation
12/21/2000WO2000076550A2 Carrier-drug conjugate
12/21/2000WO2000076496A1 Tumor tissue accumulation enhancers for drugs
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000052466A3 Measurement of tear fluorescein clearance
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000038579A3 Device and method for safe location and marking of a cavity and sentinel lymph nodes
12/21/2000WO2000037114A3 Methods and compositions comprising monitoring devices
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000CA2376473A1 Glp-1 as a diagnostic test to determine b-cell function and the presence of the condition of igt and type-ii diabetes
12/21/2000CA2375576A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374616A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000CA2340375A1 Agent for enhancing accumulation of drugs in tumor tissues
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/20/2000CN1059600C Imaging agent for ultrasonic diagnosis for stomach
12/19/2000US6162912 Process of preparing tetraacetic acid derivatives
12/19/2000US6162469 A medical powder comprising a base particle of a ferromagnetic metal having thereon at least one metal oxide layer, and an outside coating containing bioinert polymeric or copolymeric layer and a drug or medical component
12/19/2000US6162186 Non-invasive method for diagnosing alzheimer's disease in a patient
12/14/2000WO2000075141A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
12/14/2000WO2000075125A1 Noninvasive imaging of nucleic acid vectors
12/14/2000WO2000074727A2 Radiopharmaceuticals and methods for imaging
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000045855A3 Diagnostic imaging of lymph structures
12/14/2000WO2000044348A3 Materials and methods for making improved micelle compositions
12/14/2000DE19926728A1 Deformable, hardenable or film-forming carrier containing intraoral diagnostic additives, useful for the simultaneous detection of multiple oral conditions
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000DE19926154A1 Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung A process for producing an injectable medicament preparation
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/12/2000US6161034 Methods and chemical preparations for time-limited marking of biopsy sites
12/12/2000US6160108 Platelet activation protein
12/12/2000US6159445 In vivo diagnostic light imaging
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000CA2065290C Hydroxy-aryl metal chelates for diagnostic nmr imaging
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000072888A1 Multi-stage method for producing gas-filled microcapsules
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072866A1 Use of a pharmacological agent in the diagnosis of obsessive-compulsive disorder
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000CA2373869A1 Multi-stage method for producing gas-filled microcapsules
12/07/2000CA2370311A1 Prevention and treatment of amyloidogenic disease
12/06/2000EP1056474A2 Affinity markers for human serum albumin
12/06/2000EP1056473A1 Targeted delivery of biologically active media
12/06/2000EP0672172B1 Detecting digeorge syndrome mutations
12/05/2000US6156873 Bismuth dendrimers, processes for their preparation, and their use as x-ray contrast agents
12/05/2000US6156800 Drugs for cardiovascular disorders and hypotensive agents
12/05/2000US6156292 Extremely small bubbles, or ?microbubbles,? comprised of octafluoropropane, dodecafluoropentane, or decafluorobutane.
12/05/2000CA2195877C Non-invasive method for diagnosing alzheimer's disease in a patient
12/04/2000CA2273609A1 Radiopharmaceuticals and methods for imaging
11/2000
11/30/2000WO2000072037A1 Method of magnetic resonance imaging
11/30/2000WO2000071526A1 Gadolinium complex tetramides and use in medical imaging
11/30/2000WO2000071197A1 Methods for embolizing vascular sites with an embolizing composition
11/30/2000WO2000071182A1 Radiopaque compositions
11/30/2000WO2000071172A1 Site specific binding system, nuclear imaging compositions and methods
11/30/2000WO2000071170A1 Novel high viscosity embolizing compositions
11/30/2000WO2000071169A2 Magnetic resonance tracking of magnetically labeled cells
11/30/2000WO2000071167A1 Method for evaluating matrix metalloprotease inhibitory activity
11/30/2000WO2000071166A2 Process
11/30/2000WO2000071162A2 Cyanine and indocyanine dye bioconjugates for biomedical applications
11/30/2000WO2000071064A1 Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity
11/30/2000WO2000025829A3 Radiodense compositions
11/30/2000DE19925311A1 Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln Multi-stage process for the production of gas-filled microcapsules
11/30/2000CA2371915A1 Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity
11/30/2000CA2363786A1 Methods for embolizing vascular sites with an embolizing composition
11/29/2000EP1054625A1 Improvements in or relating to ultrasonography